Reese, M., Cooter, M., Roberts, K. C., Woldorff, M. G., Browndyke, J. N., Shaw, L. M., … Berger, M. (2024). Anesthetic dose‐adjusted intraoperative alpha power in association with biomarkers of preclinical Alzheimer’s disease, preoperative attention function, and postoperative delirium. Alzheimer’s & Dementia, 20(S2). https://doi.org/10.1002/alz.089088

Reese, Melody, Mary Cooter, Kenneth C. Roberts, Marty G. Woldorff, Jeffrey N. Browndyke, Leslie M. Shaw, Teresa Waligorska, Henrik Zetterberg, Kaj Blennow, and Miles Berger. “Anesthetic dose‐adjusted intraoperative alpha power in association with biomarkers of preclinical Alzheimer’s disease, preoperative attention function, and postoperative delirium.” Alzheimer’s & Dementia 20, no. S2 (December 2024). https://doi.org/10.1002/alz.089088.

Reese M, Cooter M, Roberts KC, Woldorff MG, Browndyke JN, Shaw LM, et al. Anesthetic dose‐adjusted intraoperative alpha power in association with biomarkers of preclinical Alzheimer’s disease, preoperative attention function, and postoperative delirium. Alzheimer’s & Dementia. 2024 Dec;20(S2).

Reese, Melody, et al. “Anesthetic dose‐adjusted intraoperative alpha power in association with biomarkers of preclinical Alzheimer’s disease, preoperative attention function, and postoperative delirium.” Alzheimer’s & Dementia, vol. 20, no. S2, Wiley, Dec. 2024. Crossref, doi:10.1002/alz.089088.

Reese M, Cooter M, Roberts KC, Woldorff MG, Browndyke JN, Shaw LM, Waligorska T, Zetterberg H, Blennow K, Berger M. Anesthetic dose‐adjusted intraoperative alpha power in association with biomarkers of preclinical Alzheimer’s disease, preoperative attention function, and postoperative delirium. Alzheimer’s & Dementia. Wiley; 2024 Dec;20(S2).